US Secures 300 Million Doses of Potential AstraZeneca Covid-19 Vaccine
Team Udayavani, May 22, 2020, 1:26 PM IST
AstraZeneca has received more than $1 billion from the U.S. Health Department’s Biomedical Advanced Research and Development Authority to develop a coronavirus vaccine from the University of Oxford
The United States has secured almost a third of the first one billion doses planned for AstraZeneca’s experimental Covid-19 vaccine
Alex Azar, U.S. Health Secretary said, “This contract with AstraZeneca is a major milestone in Operation Warp Speed’s work toward a safe, effective, widely available vaccine by 2021,”
The vaccine, previously known as ChAdOx1 nCoV-19 and now as AZD1222, was developed by the University of Oxford and licensed to AstraZeneca. The first doses of AZD1222 are expected to be delivered in October.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
30 detained over killing of lawyer in clash between Bangladesh police, followers of jailed Hindu leader
‘Monks targetted by Islamist elements’: ISKCON Kolkata flags Bangladesh issue to Modi govt
Jaishankar says Indo-Pacific landscape calls for wider collaborative approach, terms G7 as partner for it
Will impose 25 per cent tariff on all imports from Canada, Mexico: Trump
Internal divisions leave open question whether Gandhi’s vision will ever be fully realised in India: Bill Clinton
MUST WATCH
Latest Additions
Priests’ entry in Ayodhya Ram temple to be banned in case of death, birth in their family
Opposition spreading propaganda against NDA, crushing spirit of Constitution: PM Modi
BESCOM to organise EV expo for Secretariat employees in Jan 2025
Siddaramaiah rules out immediate Cabinet expansion, hints at Nagendra’s induction later
Mangaluru to host two-day multicultural festival from Dec 3
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.